Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PCDH10 belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. Additionally we are shipping PCDH10 Proteins (10) and PCDH10 Kits (1) and many more products for this protein.
Showing 10 out of 36 products:
Human Monoclonal PCDH10 Primary Antibody for WB - ABIN393309
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for ABIN393309
Human Polyclonal PCDH10 Primary Antibody for IF (p) - ABIN2178734
Deng, Liang, Ying, Dong, Zhang, Yu, Fan, Hao: Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. in Journal of the American College of Surgeons 2014
Human Polyclonal PCDH10 Primary Antibody for ICC, IF - ABIN4347939
Monticone, Daga, Candiani, Romeo, Mirisola, Viaggi, Melloni, Pedemonte, Zona, Giaretti, Pfeffer, Castagnola: Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells. in BMC cancer 2012
PCDH10 methylation in serum is a potential prognostic biomarker for prostate cancer.
Study found that hypermethylation of CpG probes in the promoter regions of HOXA9 and PCDH10 was associated with mature B-cell neoplasms.
Results suggest that protocadherin 10 (PCDH10)-Dishevelled, EGL-10 and Pleckstrin domain containing 1 (DEPDC1)-caspase signaling may be a novel regulatory axis in endometrial endometrioid carcinoma (EEC) development.
Data show that protocadherin 10 (PCDH10) over-expression could significantly induce cell apoptosis, and restrain proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells.
Our present findings suggested that the hypermethylated CpG site counts of PCDH10 DNA promoter for evaluating the prognosis of GC was reasonable by using the D-BGS
PCDH10 methylation is a potential biomarker that predicts a poor prognosis after curative resection of pathological stage I non-small-cell lung cancer.
PCDH10 antagonized MM cell proliferation via the downregulation of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies)/BCL-9 (show BCL9 Antibodies) signaling, whereas PCDH10 repressed the expression of AKT (show AKT1 Antibodies) to promote the expression of GSK3beta (show GSK3b Antibodies) and then to restrain the activation of beta-catenin (show CTNNB1 Antibodies)
These results suggest an important role of p53 in regulating tumor cell migration through activating PCDH10 expression.
Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.
Gastric cancer patients with 5 or more methylated CpG sites of PCDH10 promoter had significantly poorer survival.
Pcdh10, which is regulated by Pou3f1 (show POU3F1 Antibodies) and Hoxa5 (show HOXA5 Antibodies), is a mediator of like-like clustering of motor neuron cell bodies in the developing phrenic nerve.
results show that OL-pc is essential for both elongation of striatal axons and patterning of the putative guidance cues for thalamocortical projections.
The role of OL-protocadherin-dependent striatal axon growth in neural circuit formation.
This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The mRNA encodes a cadherin-related neuronal receptor thought to play a role in the establishment and function of specific cell-cell connections in the brain. This family member contains 6 extracellular cadherin domains, a transmembrane domain and a cytoplasmic tail differing from those of the classical cadherins. Alternatively spliced transcripts encode isoforms with unique cytoplasmic domains.
ortholog of OL-pcdh